Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis

NCT01104025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Hemophagocytic Lymphohistiocytosis

Interventions

DRUG: ATG, rabbit
DRUG: Etoposide
DRUG: Methotrexate
DRUG: hydrocortisone
DRUG: Dexamethasone

Sponsor

Children's Hospital Medical Center, Cincinnati